BRIEF-Krystal Biotech Announces FDA’s 3-Month Extension Of BLA PDUFA Date, Regulatory Update For B-VEC

Reuters
09 Jan 2023

Jan 9 (Reuters) - Krystal Biotech Inc :

* KRYSTAL BIOTECH ANNOUNCES FDA’S 3-MONTH EXTENSION OF BLA PDUFA DATE AND REGULATORY UPDATE FOR B-VEC TO TREAT PATIENTS WITH DYSTROPHIC EPIDERMOLYSIS BULLOSA

* KRYSTAL BIOTECH INC - PDUFA DATE HAS BEEN REVISED TO MAY 19, 2023, AND PROPOSED LABELING DISCUSSIONS TO NO LATER THAN APRIL 20, 2023

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10